wet AMD
Novartis cuts Lucentis price amid growing pressure
October 7, 2011Sales and Marketing Lucentis, wet AMD
Novartis has been forced to cut the Swiss price of its eye drug Lucentis by 30% after sharp negotiations with …
Government wrong to push for Avastin in eye disease, says charity
May 12, 2011Research and Development, Sales and Marketing Lucentis, RNIB, avastin, wet AMD
The UK government’s pursuit of Avastin for use in ophthalmology is bad for patients, says the Royal National Institute of …
Avastin as effective as Lucentis in eye disease
May 4, 2011Research and Development Lucentis, avastin, off label, wet AMD
Roche’s cancer drug Avastin is as effective at treating wet AMD as Novartis’ Lucentis, which is licensed for the eye …
Bayer’s challenger to Lucentis shows promise
November 22, 2010Research and Development, Sales and Marketing Bayer, Lucentis, Novartis, Regeneron, Roche, VEGF Trap-Eye, age-related macular degeneration, avastin, wet AMD
Phase III data for a new age-related macular degeneration (wet AMD) treatment show it is as good as Lucentis, the …
Latest content
Aiforia deal to expand access to pathology AI
October 22, 2026
SMC accepts atogepant for acute migraine treatment in Scotland
October 22, 2026
New CCO Ogburn joins Cori Clinical
October 21, 2026
Claris reports visual acuity gains with experimental LSCD treatment
October 21, 2026
Amphista doses first patient in AML trial of protein degrader
October 20, 2026
